Celoxica

wealthtech-retailother investments platform

FOUNDING YEAR: 1996
LOCATION: United Kingdom
Last Update: 17/07/2020

Subscribe to the MEDICI Inner Circle Membership and gain access to an exclusive WhatsApp community where you can engage in discussions with global industry experts!

About

Celoxica offers the fastest, most deterministic trading & market data solutions with the lowest footprint. Our solutions include a full range of market data feed handlers for the main US and European Equities, Options, Futures exchanges and FX. Celoxicas range of services are designed to deliver unique business advantage through a combination of leading edge software and hardware acceleration using FPGA-based technology to offer ultra-low latency measured in single digit microsecond and ultra-high throughput, together with accelerated Market Data, Market Access and in-Line Risk. Our clients believe that speed matters and that every microsecond counts. They are typically trading firms who co-locate (or proximity host) their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading and smart order routing. We are also providing a single access point for brokers and their clients by handling inbound FIX, credit check and outbound native protocol to the execution venues.

MEDICI Analysis

Celoxica delivers ultra-low latency market data access and order execution solutions to the advanced trading community.

Focus

MAIN CLIENTS

G. H. Financials

Thomson Reuters

Colt Technology Services

People

NUMBER OF EMPLOYEES

11-50

INVESTORS:

Credit Suisse

Goldman Sachs

Intel Capital

Invesco

Xilinx

Momentum

FUNDED

YES

TOTAL FUNDING

$34.83 M

DATE OF LAST FUNDING

Sep 2014

TOTAL FUNDING COMMENT

Remaining funding from Venture rounds.

SEED & PRIOR FUNDING

$2.4 M

FUNDING SERIES

SERIES D  · $30 M  · Oct 2001

OTHERS  · $2.43 M · Sep 2014

LISTED

NO

Join the exclusive global FinTech community

Be a part of the global FinTech community on WhatsApp